Rational design of a split-Cas9 enzyme complex - PubMed (original) (raw)
Rational design of a split-Cas9 enzyme complex
Addison V Wright et al. Proc Natl Acad Sci U S A. 2015.
Abstract
Cas9, an RNA-guided DNA endonuclease found in clustered regularly interspaced short palindromic repeats (CRISPR) bacterial immune systems, is a versatile tool for genome editing, transcriptional regulation, and cellular imaging applications. Structures of Streptococcus pyogenes Cas9 alone or bound to single-guide RNA (sgRNA) and target DNA revealed a bilobed protein architecture that undergoes major conformational changes upon guide RNA and DNA binding. To investigate the molecular determinants and relevance of the interlobe rearrangement for target recognition and cleavage, we designed a split-Cas9 enzyme in which the nuclease lobe and α-helical lobe are expressed as separate polypeptides. Although the lobes do not interact on their own, the sgRNA recruits them into a ternary complex that recapitulates the activity of full-length Cas9 and catalyzes site-specific DNA cleavage. The use of a modified sgRNA abrogates split-Cas9 activity by preventing dimerization, allowing for the development of an inducible dimerization system. We propose that split-Cas9 can act as a highly regulatable platform for genome-engineering applications.
Keywords: CRISPR-Cas9; genome engineering; split enzyme.
Conflict of interest statement
Conflict of interest statement: A.V.W., S.H.S. and J.A.D. have filed a related patent.
Figures
Fig. 1.
Cas9 can be split into two separate polypeptides that retain the ability to catalyze RNA-guided dsDNA cleavage. (A) Domain organization of WT Cas9 (Top) and split-Cas9 (Bottom), composed of the α-helical lobe and nuclease lobe. Domain junctions are numbered according to Nishimasu et al. (9). BH, bridge helix; PI, PAM-interacting; REC, recognition lobe. The PI domain can be further subdivided into Topo-homology and C-terminal domains (8). (B) Crystal structures of sgRNA/DNA-bound Cas9 (PDB ID code 4OO8) (9) colored according to domain (Left) or by lobe (Right), with the α-helical and nuclease lobes depicted in gray and blue, respectively. Nucleic acids are omitted for clarity. In the observed interface between the lobes (Inset, Left), the dashed line represents a disordered linker spanning residues V713–D718. In the engineered interface (Inset, Right), the dashed line represents a GGS linker connecting E57 to G729, and new N and C termini of the α-helical lobe are shown. (C) SDS polyacrylamide gel electrophoresis (SDS/PAGE) analysis of purified WT Cas9 (159 kDa), the α-helical lobe (77 kDa), and the nuclease lobe (81 kDa). The gel was stained with Coomassie Brilliant Blue. (D) DNA cleavage assay with the indicated Cas9 construct, analyzed by denaturing PAGE. Reactions contained ∼1 nM radiolabeled dsDNA and 100 nM protein–sgRNA complex; split-Cas9 contained a twofold molar excess of the α-helical lobe. Quantified data and kinetic analysis can be found in Fig. S2 and Table S1.
Fig. 2.
Split-Cas9 assembly requires the sgRNA. (A) Crystal structure of sgRNA/DNA-bound Cas9 (PDB ID code 4OO8) (9). Cas9 is colored by lobe and shown as a transparent surface, and the sgRNA is colored by motif according to Briner et al. (11), and the DNA is omitted for clarity. (B) Diagrams of full-length and truncated sgRNA variants used in binding experiments; specific motifs of the sgRNA are colored as in A. (C and D) Results from binding experiments using full-length sgRNA (C), and Δhairpins1-2 and Δspacer–nexus sgRNA truncations (D). Radiolabeled RNAs were incubated with increasing concentrations of WT Cas9, individual α-helical and nuclease lobes, or split-Cas9, and the fraction of protein-bound RNA was determined by nitrocellulose filter binding. Equilibrium dissociation constants (_K_d) determined from three independent experiments are shown in Table 1. (E) Reference-free class averages from negative-stain EM images of split-Cas9 reconstituted with single-guide RNA (Top Left), WT Cas9 reconstituted with dual-guide RNA (Top Right), and split-Cas9 in the absence of guide RNA (Bottom). For split-Cas9 without sgRNA, several class averages are shown. The width of the boxes corresponds to ∼336 Å. Data with WT Cas9 are adapted from Jinek et al. (8).
Fig. 3.
Genomic editing function and selective inactivation of split-Cas9. (A) Schematic of the split-Cas9 RNP nucleofection assay using a full-length _EMX1_-targeting sgRNA. Illustration and protocol adapted from Lin et al. (13). (B) Analysis of editing efficiencies by nonhomologous end joining (NHEJ) using a T7 endonuclease I assay and agarose-gel electrophoresis. Cells were nucleofected with 100, 30, or 10 pmol of WT or split-Cas9 ribonucleoprotein (RNP) complexes after arrest at mitosis with nocodazole (Sync) or during normal growth (Unsync). Editing efficiencies are shown at the bottom. (C) DNA cleavage time courses using WT and split-Cas9 with either a full-length sgRNA (Top) or the Δhairpins1-2 sgRNA (Bottom). Values were averaged from three independent experiments, and error bars represent the SD. Rate constants can be found in Table S1.
Similar articles
- RNA-dependent DNA endonuclease Cas9 of the CRISPR system: Holy Grail of genome editing?
Gasiunas G, Siksnys V. Gasiunas G, et al. Trends Microbiol. 2013 Nov;21(11):562-7. doi: 10.1016/j.tim.2013.09.001. Epub 2013 Oct 1. Trends Microbiol. 2013. PMID: 24095303 - Genome editing using Cas9 nickases.
Trevino AE, Zhang F. Trevino AE, et al. Methods Enzymol. 2014;546:161-74. doi: 10.1016/B978-0-12-801185-0.00008-8. Methods Enzymol. 2014. PMID: 25398340 - Programmable DNA cleavage in vitro by Cas9.
Karvelis T, Gasiunas G, Siksnys V. Karvelis T, et al. Biochem Soc Trans. 2013 Dec;41(6):1401-6. doi: 10.1042/BST20130164. Biochem Soc Trans. 2013. PMID: 24256227 Review. - In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.
Anders C, Niewoehner O, Jinek M. Anders C, et al. Methods Enzymol. 2015;558:515-537. doi: 10.1016/bs.mie.2015.02.008. Epub 2015 Mar 12. Methods Enzymol. 2015. PMID: 26068752 Free PMC article. - CRISPR/Cas9 for genome editing: progress, implications and challenges.
Zhang F, Wen Y, Guo X. Zhang F, et al. Hum Mol Genet. 2014 Sep 15;23(R1):R40-6. doi: 10.1093/hmg/ddu125. Epub 2014 Mar 20. Hum Mol Genet. 2014. PMID: 24651067 Review.
Cited by
- Advances in targeting cancer epigenetics using CRISPR-dCas9 technology: A comprehensive review and future prospects.
Rajanathadurai J, Perumal E, Sindya J. Rajanathadurai J, et al. Funct Integr Genomics. 2024 Sep 18;24(5):164. doi: 10.1007/s10142-024-01455-3. Funct Integr Genomics. 2024. PMID: 39292321 Review. - CRISPR technology in human diseases.
Feng Q, Li Q, Zhou H, Wang Z, Lin C, Jiang Z, Liu T, Wang D. Feng Q, et al. MedComm (2020). 2024 Jul 29;5(8):e672. doi: 10.1002/mco2.672. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39081515 Free PMC article. Review. - Inducible RNA targeting and N6-methyladenosine editing by a split-Cas13 architecture.
Li Y, Sun Q, Yang Z, Yuan G. Li Y, et al. J Mol Cell Biol. 2024 Jul 1;16(1):mjae002. doi: 10.1093/jmcb/mjae002. J Mol Cell Biol. 2024. PMID: 38216515 Free PMC article. No abstract available. - Expression and Functional Analysis of the Compact Thermophilic Anoxybacillus flavithermus Cas9 Nuclease.
Matveeva A, Ryabchenko A, Petrova V, Prokhorova D, Zhuravlev E, Zakabunin A, Tikunov A, Stepanov G. Matveeva A, et al. Int J Mol Sci. 2023 Dec 4;24(23):17121. doi: 10.3390/ijms242317121. Int J Mol Sci. 2023. PMID: 38069443 Free PMC article. - A qPCR Method to Assay Endonuclease Activity of Cas9-sgRNA Ribonucleoprotein Complexes.
Nguyen MT, Kim SA, Cheng YY, Hong SH, Jin YS, Han NS. Nguyen MT, et al. J Microbiol Biotechnol. 2023 Sep 28;33(9):1228-1237. doi: 10.4014/jmb.2305.05010. Epub 2023 Jun 19. J Microbiol Biotechnol. 2023. PMID: 37415091 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials